Jump to contentJump to search

Düsseldorf-Jülich Symposium on Neurodegenerative Diseases:

Meeting the challenges of Alzheimer's disease: from basic science to clinical translation

 

Program


Thursday, October 29, 2015

 

Welcome

Chair: Dieter Willbold, Heinrich Heine University Düsseldorf and Forschungszentrum Jülich

9:20 Opening address

Anja Steinbeck, President of Heinrich Heine University Düsseldorf, Germany

9:30 Introduction and History

Thomas van Groen, University of Alabama at Birmingham, AL, USA

10:30 break

 

 

Session I

Chair: Linda J. van Eldik, University of Kentucky, USA

10:45 Moonlighting functions of the beta-secretase - new insights for current and future therapeutic approaches

Gerhard Multhaup, McGill University, Montreal, QC, Canada

11:45 Alzheimer's disease: moving from symptomatic to protein diagnosis

Philip Scheltens, VU University Medical Center Amsterdam, the Netherlands

Lunch (12:45-13:45)

 

 

Session II

Chair: Oliver Bannach, Heinrich Heine University Düsseldorf

13:45 Identification and validation of novel protein biomarkers for FTD

Charlotte Teunissen, VU University Medical Center Amsterdam, the Netherlands

14:45 Non-tubulin functions of the microtubule-associated Tau protein

Marie-Christine Galas, Institut national de la santé et de la recherche médicale, Lille, France

15:45 break

 

 

Session III

Chair: Antje Willuweit, Forschungszentrum Jülich

16:00 Transgenic animal models for drug development in Alzheimer´s disease: We succeed in mice and fail in human clinical trials!

Manfred Windisch, NeuroScios GmbH, St. Radegund/Graz, Austria

17:00 Poster session (with food and drinks)

 

Friday, October 30, 2015

 

Session IV

Chair: Manfred Windisch, NeuroScios GmbH, St. Radegund/Graz, Austria

9:15 From concussion to dementia: targeting dysregulated brain inflammation

Linda J. van Eldik, University of Kentucky, USA

10:15 Alzheimer's disease: paradigm of pre-clinical success & clinical failure

Fred van Leuven, KU Leuven, Belgium

11:15 break

 

Chair: Janine Kutzsche

11:30 Posttranslational modification of APP leading to different toxic Abeta- species

Hans-Ulrich Demuth, Fraunhofer Institute, Halle, Germany

Lunch (12:30-13:30)

 

 

Session VI

Chair: Inga Kadish, University of Alabama at Birmingham, AL, USA

13:30 Naturally occurring autoantibodies and Alzheimer's disease

Richard Dodel, Philipps-University Marburg, Germany

14:30 Biophysical approaches to probe protein aggregation

Tuomas Knowles, University of Cambridge, UK

15:30 break

 

Session VII

Chair: Thomas van Groen, University of Alabama at Birmingham, AL, USA

16:00 Alzheimer´s disease pathology and transneuronal degeneration

Thomas Deller, Goethe University, Frankfurt, Germany

17:00 End of symposium

Thomas van Groen, University of Alabama at Birmingham, AL, USA

Responsible for the content: